Example #1: Investors may obtain a free copy of the proxy statement, as well as other filings containing information about Chemical Financial and OAK, free of charge from the SEC's website (www.sec.gov); by contacting Chemical Financial Corporation, 333 East Main Street, PO Box 569, Midland, MI 48640-0569, Attention: Ms. Lori A. Gwizdala, Investor Relations, telephone 800-867-9757 or by contacting O.A.K. Financial Corporation, 2445 84th Street, SW, Byron Center, MI 49315, Attention: Mr. James A. Luyk, Investor Relations, telephone 616-599-7419.
Expected output: 'entities: [{'span': 'Chemical Financial', 'entity': 'Business'}, {'span': 'OAK', 'entity': 'Business'}, {'span': 'SEC', 'entity': 'Government'}, {'span': 'Chemical Financial Corporation', 'entity': 'Business'}, {'span': 'East Main Street', 'entity': 'Location'}, {'span': 'Midland', 'entity': 'Location'}, {'span': 'MI', 'entity': 'Location'}, {'span': 'Lori A. Gwizdala', 'entity': 'Person'}, {'span': 'O.A.K. Financial Corporation', 'entity': 'Business'}, {'span': '84th Street, SW', 'entity': 'Location'}, {'span': 'Byron Center', 'entity': 'Location'}, {'span': 'James A. Luyk', 'entity': 'Person'}]'

Example #2: Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Seattle, State of Washington, on April 1, 2011.
Expected output: 'entities: [{'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Form S-3', 'entity': 'Miscellaneous'}, {'span': 'City of Seattle', 'entity': 'Location'}, {'span': 'State of Washington', 'entity': 'Location'}]'

Example #3: We, the undersigned directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.
Expected output: 'entities: [{'span': 'Acorda Therapeutics, Inc.', 'entity': 'Business'}, {'span': 'Ron Cohen', 'entity': 'Person'}, {'span': 'Form S-8', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #4: In connection with the Quarterly Report of Polonia Bancorp (the “ Company ”) on Form 10-Q for the quarter ended March 31, 2011 as filed with the Securities and Exchange Commission (the “ Report ”), the undersigned hereby certify, pursuant to 18 U.S.C. § 1350, as added by § 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Polonia Bancorp', 'entity': 'Business'}, {'span': 'Form 10-Q', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

Example #5: The Company is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), and in accordance therewith files reports, proxy statements and other information including annual and quarterly reports on Form 10-K and 10-Q (the “ 1934 Act Filings ”) with the Securities and Exchange Commission (the “ Commission ”).
Expected output: 'entities: [{'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': '10-Q', 'entity': 'Miscellaneous'}, {'span': '1934 Act Filings', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #6: Morgan Securities executed on June 17, 2011, a Consent of Defendant J.P. Morgan Securities (the “ Consent ”), in which J.P. Morgan Securities neither admitted nor denied any of the allegations (except as to personal and subject matter jurisdiction) in a complaint filed by the Commission, but in which it consented to the entry of a final judgment (“ Final Judgment ”) against it by the United States District Court for the Southern District of New York (the “ Court ”).
Expected output: 'entities: [{'span': 'Morgan Securities', 'entity': 'Business'}, {'span': 'J.P. Morgan Securities', 'entity': 'Business'}, {'span': 'United States District Court for the Southern District of New York', 'entity': 'Court'}]'

Example #7: This Information Statement has been filed with the Securities and Exchange Commission and is being furnished, pursuant to Section 14C of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), to the holders (the “ Stockholders ”) of the common stock, par value $ .0001 per share (the “ Common Stock ”), of Comcam, Inc., a Delaware Corporation (the “ Company ”), to notify such Stockholders that on or about March 5, 2010, the Company received written consents in lieu of a meeting of Stockholders from holders of 683,952,500 shares representing approximately 91 % of the 744,640,134 shares of the total issued and outstanding shares of voting stock of the Company (the “ Majority Stockholders ”) to authorize 1-for-85 reverse stock split (pro-rata reduction of outstanding shares) of our issued and outstanding shares of Common Stock (the “ Reverse Stock Split ”).
Expected output: 'entities: [{'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Comcam, Inc.', 'entity': 'Business'}, {'span': 'Delaware', 'entity': 'Location'}]'

Example #8: Dominic Minore Securities and Exchange Commission Investment Company Division 100 F. Street, N.E.
Expected output: 'entities: [{'span': 'Dominic Minore', 'entity': 'Person'}, {'span': 'Securities', 'entity': 'Government'}, {'span': 'and Exchange Commission Investment Company Division', 'entity': 'Government'}, {'span': 'F. Street', 'entity': 'Location'}, {'span': 'N.E.', 'entity': 'Location'}]'

Example #9: Dominic Minore Securities and Exchange Commission Investment Company Division 100 F. Street, N.E.
Expected output: 'entities: [{'span': 'Dominic Minore', 'entity': 'Person'}, {'span': 'Securities', 'entity': 'Government'}, {'span': 'and Exchange Commission Investment Company Division', 'entity': 'Government'}, {'span': 'F. Street', 'entity': 'Location'}, {'span': 'N.E.', 'entity': 'Location'}]'

Example #10: IPOs On October 1, 2003, the Commission filed a complaint (the “ IPO Complaint ”) against J.P. Morgan Securities Inc. (predecessor to JPMS, “ JPMSI ”) in the United States District Court for the District of Columbia (the “ D.C. District Court ”) in a civil action captioned Securities and Exchange Commission v. J.P. Morgan Securities Inc..
Expected output: 'entities: [{'span': 'IPO Complaint', 'entity': 'Miscellaneous'}, {'span': 'J.P. Morgan Securities Inc.', 'entity': 'Business'}, {'span': 'JPMS', 'entity': 'Business'}, {'span': 'JPMSI', 'entity': 'Business'}, {'span': 'United States District Court for the District of Columbia', 'entity': 'Court'}, {'span': 'D.C. District Court', 'entity': 'Court'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

